Ackman: Allergan Rules For Shareholder Meetings Too Onerous - Presented by: The Aol. On Network

Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has stacked the odds against a special shareholders meeting. Pershing Square Capital Management, which is led by Bill Ackman, is attempting to muster at least 25 percent support of Allergan shares to hold a special meeting that could replace most of the Botox anti-wrinkle injection maker's board, which has refused to negotiate with Valeant.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16 0.16 ▲ 1.01%
AAPL $ 126.41 2.13 ▼ 1.66%
VALE $ 6.53 0.35 ▼ 5.09%
ABBV $ 56.86 3.41 ▼ 5.66%
PBR $ 6.08 0.10 ▼ 1.62%
RAD $ 7.68 0.37 ▼ 4.60%
AVP $ 9.05 0.05 ▼ 0.55%
ECA $ 11.79 0.48 ▼ 3.91%

As of 3/5/2015, 04:15 PM More Most Active